Search

Your search keyword '"Ronit Marom"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Ronit Marom" Remove constraint Author: "Ronit Marom" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
58 results on '"Ronit Marom"'

Search Results

1. Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signaling.

2. Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance

4. Identification of novel candidate disease genes from de novo exonic copy number variants

5. Retrospective analysis of a clinical exome sequencing cohort reveals the mutational spectrum and identifies candidate disease–associated loci for BAFopathies

6. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

7. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

8. PhenoScore: AI-based phenomics to quantify rare disease and genetic variation

9. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

11. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

12. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

13. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

14. One is the loneliest number: genotypic matchmaking using the electronic health record

15. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases

16. Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies

17. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

18. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

19. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

20. A Novel De Novo Intronic Variant in ITPR1 Causes Gillespie Syndrome

21. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

22. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

23. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

24. Drosophilafunctional screening ofde novovariants in autism uncovers deleterious variants and facilitates discovery of rare neurodevelopmental diseases

25. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

26. DELAYED SKELETAL DEVELOPMENT IN A MOUSE MODEL OF GLOBAL DEFICIENCY

27. COPB2haploinsufficiency causes a coatopathy with osteoporosis and developmental delay

28. A Somnolent Neonate With Hypothermia and Posturing

29. Osteogenesis imperfecta: an update on clinical features and therapies

30. A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance

31. Recurrent Arginine Substitutions in the ACTG2 Gene are the Primary Driver of Disease Burden and Severity in Visceral Myopathy

32. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

33. List of contributors

35. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

36. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

37. Neonatal fractures as a presenting feature of LMOD3 ‐associated congenital myopathy

38. Heterozygous variants inACTL6A, encoding a component of the BAF complex, are associated with intellectual disability

39. Pharmacological and biological therapeutic strategies for osteogenesis imperfecta

40. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

41. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

42. Correction: Variants in MED12L, encoding a subunit of the Mediator kinase module, are responsible for intellectual disability associated with transcriptional defect

44. Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect

45. Anovel de novo intronic variant in ITPR1 causes Gillespie syndrome

46. IRF2BPL Is Associated with Neurological Phenotypes

47. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

48. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features

49. A Transgenic Mouse Model of OI Type V Supports a Neomorphic Mechanism of theIFITM5Mutation

50. Identification of novel candidate disease genes from de novo exonic copy number variants

Catalog

Books, media, physical & digital resources